A robust immune-related lncRNA signature for the prognosis of human colorectal cancer.
Gongmin ZhuLijiao PeiFan YangChenliang ZhangPublished in: Bioscience reports (2022)
The constructed 9-IRlncRNA signature has potential to predict the prognosis of CRC patients and may be helpful to guide personalized immunotherapy.